Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

TELESTA THERAPEUTICS INC
Bullboard Posts
User Avatar Image
(0)
•••
Post by Bagatrixon Aug 06, 2010 1:45pm
866 Views
Post# 17328648

Could it be the day we are all hoping for?

Could it be the day we are all hoping for?

Endo to Present at the Bank of AmericaMerrill Lynch 2010 Specialty Pharmaceuticals Conference

Friday, August 06, 2010

CHADDS FORD, Pa., Aug.6 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP)today announced that it will present at the Bank of America Merrill Lynch 2010Specialty Pharmaceuticals Conference onThursday,August 12, 2010, at 8:00 a.m. EDT.  Alan Levin, executive vice president and chief financial officer ofEndo, will review the company's productsand development programs.

The presentation will be webcast live and can be accessed from Endo'swebsite at www.endo.com under theinvestors section.  

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities